FAM210A regulates mitochondrial translation and maintains cardiac mitochondrial homeostasis
Cardiovascular Research · 15.11.2023 · 119 (14) · 2441-2457
DOI: 10.1093/cvr/cvad124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 31.07.2023. Verfasst von Jiangbin Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Aab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine & Dentistry, 601 Elmwood Avenue, Rochester,…. Hauptthemen laut MEDLINE: Heart Failure, Ventricular Remodeling. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Aims
Mitochondria play a vital role in cellular metabolism and energetics and support normal cardiac function. Disrupted mitochondrial function and homeostasis cause a variety of heart diseases. Fam210a (family with sequence similarity 210 member A), a novel mitochondrial gene, is identified as a hub gene in mouse cardiac remodelling by multi-omics studies. Human FAM210A mutations are associated with sarcopenia. However, the physiological role and molecular function of FAM210A remain elusive in the heart. We aim to determine the biological role and molecular mechanism of FAM210A in regulating mitochondrial function and cardiac health in vivo. Methods and results Tamoxifen-induced αMHCMCM-driven conditional knockout of Fam210a in the mouse cardiomyocytes induced progressive dilated cardiomyopathy and heart failure, ultimately causing mortality. Fam210a deficient cardiomyocytes exhibit severe mitochondrial morphological disruption and functional decline accompanied by myofilament disarray at the late stage of cardiomyopathy. Furthermore, we observed increased mitochondrial reactive oxygen species production, disturbed mitochondrial membrane potential, and reduced respiratory activity in cardiomyocytes at the early stage before contractile dysfunction and heart failure. Multi-omics analyses indicate that FAM210A deficiency persistently activates integrated stress response, resulting in transcriptomic, translatomic, proteomic, and metabolomic reprogramming, ultimately leading to pathogenic progression of heart failure. Mechanistically, mitochondrial polysome profiling analysis shows that FAM210A loss of function compromises mitochondrial mRNA translation and leads to reduced mitochondrial-encoded proteins, followed by disrupted proteostasis. We observed decreased FAM210A protein expression in human ischaemic heart failure and mouse myocardial infarction tissue samples. To further corroborate FAM210A function in the heart, AAV9-mediated overexpression of FAM210A promotes mitochondrial-encoded protein expression, improves cardiac mitochondrial function, and partially rescues murine hearts from cardiac remodelling and damage in ischaemia-induced heart failure.
Conclusion
These results suggest that FAM210A is a mitochondrial translation regulator to maintain mitochondrial homeostasis and normal cardiomyocyte contractile function. This study also offers a new therapeutic target for treating ischaemic heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine & Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA.
- Department of Biochemistry & Biophysics, University of Rochester School of Medicine & Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA.
- Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
- The Center for RNA Biology, University of Rochester School of Medicine & Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA.
- The Center for Biomedical Informatics, University of Rochester School of Medicine & Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA.
ORCID-Profile: Jiangbin Wu, Chen Yan, Peng Yao
Förderung
- NIGMS NIH HHS
- NHLBI NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- Aab Cardiovascular Research Institute of the University of Rochester Medical Center
- American Heart Association Postdoctoral Fellowship
- Career Development Award
- NIH T32 Fellowship
Zitieren
APA
Wu, J., Subbaiah, K. C. V., Hedaya, O., Chen, S., Munger, J., Tang, W. H. W., Yan, C., & Yao, P. (2023). FAM210A regulates mitochondrial translation and maintains cardiac mitochondrial homeostasis. Cardiovascular Research, 119(14), 2441-2457. https://doi.org/10.1093/cvr/cvad124
Vancouver
Wu J, Subbaiah KCV, Hedaya O, Chen S, Munger J, Tang WHW, et al. FAM210A regulates mitochondrial translation and maintains cardiac mitochondrial homeostasis. Cardiovascular Research. 2023;119(14):2441-2457. doi:10.1093/cvr/cvad124
BibTeX
@article{Wu2023,
author = {Wu, Jiangbin and Subbaiah, Kadiam C Venkata and Hedaya, Omar and Chen, Si and Munger, Joshua and Tang, Wai Hong Wilson and Yan, Chen and Yao, Peng},
title = {FAM210A regulates mitochondrial translation and maintains cardiac mitochondrial homeostasis},
journal = {Cardiovascular Research},
year = {2023},
volume = {119},
number = {14},
pages = {2441--2457},
doi = {10.1093/cvr/cvad124}
}
EUVIMED